Envoy Medical
COCH
24 hedge funds and large institutions have $2.95M invested in Envoy Medical in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
33% more funds holding
Funds holding: 18 → 24 (+6)
4.68% more ownership
Funds ownership: 5.27% → 9.95% (+4.7%)
12% less capital invested
Capital invested by funds: $3.33M → $2.95M (-$384K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$901K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$475K |
| 3 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$220K |
| 4 |
LSAG
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
+$103K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$98.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$38.1K |
| 2 |
WAM
WealthTrust Asset Management
Destin,
Florida
|
-$36.8K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$32.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.87K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$32 |
COCH Hedge Fund Activity: Q4 2024 in Review
24 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2024, worth a combined $2.95M — down 12% from $3.33M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new COCH positions and 3 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Weiss Asset Management, opening a new position worth an estimated $901K. The largest seller was Marquette Asset Management, exiting entirely with an estimated $38.1K sold.
- 24 institutional investors held Envoy Medical (COCH) as of Q4 2024, up from 18 in Q3 2024.
- Funds reported $2.95M of Envoy Medical stock for Q4 2024, down 12% quarter-over-quarter.
- 9 funds opened new Envoy Medical positions in Q4 2024 and 3 closed out, a net change of +6 holders.
- The largest Envoy Medical buyer in Q4 2024 was Weiss Asset Management, an estimated $901K added.
- The largest Envoy Medical seller in Q4 2024 was Marquette Asset Management, an estimated $38.1K sold.
Based on aggregated 13F filings for Q4 2024.